CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) announced the CE marks of its Vscan Air™ SL wireless handheld ultrasound system with Caption AI™ (Vscan Air SL with Caption AI), an artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care, as well as ECG-less Cardiac computed tomography (CT) scanning on its Revolution Apex™ platform, which allows clinicians to acquire cardiac images without the aid of the patients’ electrocardiogram (ECG) signal/trace.

芝加哥-（商业新闻）-今天，GE HealthCare（纳斯达克股票代码：GEHC）宣布其Vscan Air™SL无线手持超声波系统的CE标志，该系统带有Caption AI™（Vscan Air SL with Caption AI），这是一种人工智能（AI）驱动的软件，用于在护理点进行快速心脏评估，以及在其Revolution Apex™平台上进行无心电图心脏计算机断层扫描（CT）扫描，该平台允许临床医生在无需患者心电图（ECG）信号/描迹的帮助下获取心脏图像。

Both technologies will be showcased at the European Society of Cardiology (ESC) Congress, in London, August 30-September 2, 2024..

这两项技术将在2024年8月30日至9月2日于伦敦举行的欧洲心脏病学会（ESC）大会上展示。。

Cardiovascular diseases are the leading cause of death globally, claiming an estimated 17.9 million lives each year. There is an urgent need to diagnose cardiovascular disease earlier to help curb cardiac deaths across the world as more than 60% of these deaths are preventable and premature.1,2 In order to meet this challenge, clinicians across various care areas need the best possible tools and technologies to diagnose and treat cardiovascular disease more efficiently to enable better patient outcomes..

心血管疾病是全球死亡的主要原因，估计每年夺去1790万人的生命。迫切需要尽早诊断心血管疾病，以帮助遏制世界各地的心脏死亡，因为这些死亡中有60%以上是可预防的和过早的。1,2为了应对这一挑战，各个护理领域的临床医生需要最好的工具和技术，以更有效地诊断和治疗心血管疾病，从而获得更好的患者预后。。

GE HealthCare will showcase its latest technology that brings high-quality imaging to the patient’s bedside, cardiac catheterization laboratory and other hospital settings. The ultraportable Vscan Air SL with Caption AI is designed to help more healthcare professionals capture cardiac images so that even non-experts in cardiac ultrasound can help tell the story of their patients’ hearts, better informing diagnoses and treatment plans.

GE HealthCare将展示其最新技术，为患者的床边、心脏导管插入术实验室和其他医院环境带来高质量的成像。带字幕AI的超便携式Vscan Air SL旨在帮助更多医疗保健专业人员捕捉心脏图像，以便即使是非心脏超声专家也可以帮助讲述患者心脏的故事，更好地为诊断和治疗计划提供信息。

Access to this novel technology enables earlier heart disease detection and expands cardiac care into primary care and emergency settings. Vscan Air SL with Caption AI can provide real-time, step-by-step visual guidance to optimize probe movements and includes a quality meter to ensure the user obtains the best possible images.

使用这种新技术可以早期发现心脏病，并将心脏护理扩展到初级保健和急诊环境。带有字幕AI的Vscan Air SL可以提供实时、逐步的视觉指导，以优化探头运动，并包括一个质量计，以确保用户获得尽可能最佳的图像。

Once a user captures an image, the AutoEF (ejection fraction) feature automatically calculates a left ventricular ejection fraction (LVEF), an important measure of heart function..

一旦用户捕获图像，AutoEF（射血分数）功能会自动计算左心室射血分数（LVEF），这是衡量心脏功能的重要指标。。

During the ESC Congress, three dedicated educational tutorials will be held on-site for Vscan Air SL with Caption AI, including live scanning demonstrations. Find out more here.

在ESC大会期间，将为Vscan Air SL现场举行三次专门的教育教程，标题为AI，包括实时扫描演示。在此处了解更多信息。

“With diseases of the heart and blood vessels representing nearly one-third of all global deaths, innovation within cardiac diagnostics and treatment is one of our top priorities as a healthcare company,” said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare.

GE healthcare超声波和图像引导疗法总裁兼首席执行官Phil Rackliffe表示：“由于心脏和血管疾病占全球死亡人数的近三分之一，因此心脏诊断和治疗领域的创新是我们作为医疗保健公司的重中之重。”。

“The integration of Caption AI on Vscan Air SL is a major step toward helping more users confidently capture diagnostic-quality images to inform clinical decisions when time is of the essence. With the recent CE mark, we’re eager to bring this technology to more healthcare providers around the world.”.

“在Vscan Air SL上集成Caption AI是朝着帮助更多用户自信地捕获诊断质量图像以告知临床决策（时间至关重要）迈出的重要一步。凭借最近的CE标志，我们渴望将这项技术带给世界各地更多的医疗保健提供商。”。

GE HealthCare will also be showcasing the recently CE marked and U.S. FDA cleared ECG-less Cardiac CT solution, which can acquire cardiac images without the aid of the patients’ ECG signal/trace. This technology is applied in examinations where it is clinically advantageous to prioritize patient access or speed when the ECG signal is unavailable.

GE HealthCare还将展示最近CE标记的美国FDA批准的无ECG心脏CT解决方案，该解决方案无需患者的ECG信号/痕迹即可获取心脏图像。该技术应用于临床上有利的检查中，当ECG信号不可用时，优先考虑患者访问或速度。

ECG-less Cardiac CT scanning is exclusively available on and further enhances the capabilities of the company’s Revolution Apex Elite, which already boasts a 160mm detector configuration and the ability to achieve one-beat, high definition, motion-free coronary images at any heart rate. This system is available as a part of GE HealthCare’s broader Revolution Apex platform, a world class scalable CT solution that offers modern computed tomography (CT) technology to provide versatile clinical solutions for even the most challenging patients..

无心电图心脏CT扫描仅在该公司的Revolution Apex Elite上提供，并进一步增强了该公司的能力，该公司已经拥有160mm的探测器配置，并能够在任何心率下实现单次搏动，高清，无运动的冠状动脉图像。该系统是GE HealthCare更广泛的Revolution Apex平台的一部分，该平台是一个世界级的可扩展CT解决方案，提供现代计算机断层扫描（CT）技术，为即使是最具挑战性的患者提供多功能的临床解决方案。。

The advanced technology is further enhanced with Effortless Workflow, which intelligently automates the CT workflow from pre-scan protocoling to post-scan processing, using AI-based features to help transform the entire CT experience and provide optimal efficiency, accuracy, clarity and consistency.

通过轻松的工作流程进一步增强了先进技术，该工作流程智能地自动化了CT工作流程，从扫描前协议到扫描后处理，使用基于AI的功能来帮助转换整个CT体验，并提供最佳的效率，准确性，清晰度和一致性。

This enables technologists to personalize scans automatically and accurately for each patient with significantly less effort. The results are high quality CT images acquired more quickly and efficiently: 56% reduction in positioning time3; 66% reduction in total exam clicks4; and 21% reduction in total exam time5..

这使技术人员能够以更少的工作量为每位患者自动准确地个性化扫描。结果是更快，更有效地获得高质量的CT图像：定位时间减少56%3；考试点击总数减少66%4；总考试时间减少21%5。。

“Providing rapid, flexible and at the point of care cardiac diagnostics is critical in terms of patient outcomes – however, timely care can be extremely difficult to deliver, particularly within already-stretched healthcare systems where clinicians face time and resource constraints,” said Eigil Samset, general manager, Cardiology Solutions, GE HealthCare.

GE healthcare心脏病学解决方案总经理Eigil Samset说：“提供快速、灵活和即时的心脏诊断对于患者预后至关重要，然而，及时护理可能极为困难，特别是在已经捉襟见肘的医疗保健系统中，临床医生面临时间和资源限制。”。

“Through our innovative cardiology solutions and by leveraging the power of AI, we aim to address these challenges and help clinicians understand the complete story of their patients’ hearts as quickly as possible. I am thrilled that this suite of integrated cardiac care solutions is now accessible to more providers so that they are able to deliver efficient and timely patient care when and where it is needed most.”.

“通过我们创新的心脏病学解决方案和利用人工智能的力量，我们的目标是应对这些挑战，并帮助临床医生尽快了解患者心脏的完整故事。我很高兴这套集成的心脏护理解决方案现在可供更多的提供者使用，以便他们能够在最需要的时候和地点提供高效及时的患者护理。”。

Building on the recent CE marks, these innovative cardiology solutions will be on display at GE HealthCare Booth # F400 South in a fully functional cardiac catheterization laboratory at ESC Congress 2024. The lab will showcase the company’s latest image guided platform Allia™ IGS 5 Pulse, designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology, as well as feature INTERACT Touch with AVVIGO+™ Multi-Modality Guidance System from Boston Scientific6 - the first third party application available with this technology..

在最近的CE标志的基础上，这些创新的心脏病学解决方案将在2024年ESC大会上，在功能齐全的心脏导管插入术实验室的GE HealthCare Booth#F400 South展出。该实验室将展示该公司最新的图像引导平台Allia™IGS 5 Pulse，该平台旨在改进介入心脏病学心血管疾病诊断和治疗的工作流程，以及与波士顿科学公司的AVVIGO+™多模式引导系统（这是该技术的第一个第三方应用程序）的功能交互触摸。。

About GE HealthCare Technologies Inc.

关于GE HealthCare Technologies Inc

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

GE HealthCare是全球领先的医疗技术、药物诊断和数字解决方案创新者，致力于提供集成的解决方案、服务和数据分析，使医院更高效、临床医生更有效、治疗更精确，患者更健康、更快乐。

Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring.

GE HealthCare为患者和提供者服务了125多年，正在推进个性化、互联化和富有同情心的护理，同时简化患者跨越护理路径的旅程。我们的成像、超声波、患者护理解决方案和药物诊断业务共同帮助改善患者护理，从诊断到治疗再到监测。

We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits..

我们是一家价值196亿美元的企业，拥有约51000名员工，致力于创造一个医疗保健无限的世界。。